LOS ANGELES, Aug.  04, 2026  (GLOBE NEWSWIRE) -- Schall, Brown &amp; Schwartz LLP (&#34;SBS&#34;), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation

PODD

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law

Insulet Faces Securities Class Action Over Manufacturing Issues

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>LOS ANGELES, Aug.  04, 2026  (GLOBE NEWSWIRE) -- Schall, Brown &amp;amp; Schwartz LLP (&amp;#34;SBS&amp;#34;), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Schall, Brown &amp; Schwartz filed a securities class action against Insulet (PODD) alleging misleading statements tied to manufacturing controls and a March 2026 Pod product recall. The case covers February 21, 2025 to May 26, 2026 with a deadline of August 31, 2026. The suit introduces downside risk to PODD’s valuation until facts are resolved.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Insulet (PODD) faces securities class action over manufacturing controls.</li><li>Lawsuit period: Feb 21, 2025–May 26, 2026; lead-plaintiff deadline: Aug 31, 2026.</li><li>March 2026 Pod product recall tied to manufacturing deficiencies.</li><li>Litigation overhang may pressure PODD’s valuation until facts are clarified.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Insulet Corporation (PODD)</strong>: Subject of the suit alleging misleading statements related to manufacturing controls; potential impact on operations and valuation.</li><li><strong>Schall, Brown &amp; Schwartz LLP (SBS)</strong>: Plaintiff-law firm leading the class-action; public filings may influence sentiment but no direct financial impact yet.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Legal: Securities litigation involving Insulet (PODD) aligns with acknowledged securities-law claims and potential impact on investor perception and valuation.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Class-action filing heights investor scrutiny of PODD&#039;s manufacturing controls.</li><li>Lead-plaintiff deadline August 31, 2026 could trigger further legal updates.</li><li>No additional recall news beyond March 2026 recall; sentiment remains sensitive.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Class period: February 21, 2025 to May 26, 2026.</li><li>Deadline for lead plaintiff applications: August 31, 2026.</li><li>March 2026 recall impacted Pod Products due to manufacturing deficiencies.</li><li>Insulet Corporation ticker: PODD.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term overhang on PODD from litigation risk; expect volatility until case developments clarify.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="left">LOS ANGELES, Aug.  04, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=HFCbdazvOLi7rXDaYBuFjN8sgHUwab_VUtQmZD-Pq-Otj23W633Tvu-pPeYZzSIe6ViEp0eqrzN3Oh2ZaO6BgvAr8ficrRcsUqucP-_3cr-GLLElx583gkEgZdDDx62X" rel="nofollow" target="_blank">Schall, Brown &amp; Schwartz LLP</a> ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation ("Insulet" or "the Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PODD">PODD</a>) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.</p>  <p align="left">Shareholders who purchased shares of PODD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.</p>  <p align="left"><strong>CLASS PERIOD:</strong> February 21, 2025 to May 26, 2026</p>  <p align="left"><strong>DEADLINE: </strong>August 31, 2026</p>  <p align="left">If you are a shareholder who suffered a loss, <a href="https://www.globenewswire.com/Tracker?data=dhOzh4UY9qDn3ZRVK9dDCsMKCaU9kq6nzV5MPhUKSI7NMMD5wg-Vjab1MP39xX0qT3GG4t7S9rtozBVZE7RcIC4BwpBhK5AFlZu_if7_9VoGcLp5PXh6JWelD6vZzs9txCec7-O-9qJjNd8NOfzdjw==" rel="nofollow" target="_blank">click here to participate</a>.</p>  <p align="left"><strong>CASE DETAILS: </strong>According to the Complaint, the Company made false and misleading statements to the market. Insulet suffered from defective controls over its manufacturing processes. The Company faced increased risks of safety violations due to these deficiencies. The Company’s manufacturing problem necessitating its March 2026 Medical Device Cirrection impacted a greater number of its Pod Products than it claimed. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Insulet, investors suffered damages.</p>  <p align="left">We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown &amp; Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm&#39;s website at <a href="https://www.globenewswire.com/Tracker?data=0c8qlGmAZmm4DaYtx84VPn3veKEO3vU8f6mj-VO5TTkGdQ6McYEuiYbJmx-jQxTSmcSEJNUTFvqY2yyNekYzHBxf3pwSGTm27hyy3dhY71o=" rel="nofollow" target="_blank"><u>www.schallfirm.com</u></a>, or by email at <a href="https://www.globenewswire.com/Tracker?data=nGY6nJ_HX0KtPF7bTpHMh5A_ws7WMB2zQx_ECBvN32GJ-Wq1B0DcfcC-7Z78VT_9NNvU5UK3cFRgcpCMzdfGVG3BoRfR00EZw0YppSPKxHY=" rel="nofollow" target="_blank">david@schallfirm.com</a>.</p>  <p align="left">The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.</p>  <p align="left"><a href="https://www.globenewswire.com/Tracker?data=ynxRnd2mkVxJzvB8923Zl0x3CcKsDykWwlV72APzgoDj0Exr83dGuBuKuo_GhgwhMb2-ab7uVISNzPJn7tX6cjqegqLuk7-F9qpLIRlfhd1fU-YK3qpVe6zpjSULjUoq" rel="nofollow" target="_blank">Join the case</a> to recover your losses</p>  <p align="left"><strong>WHY SBS?</strong> Schall, Brown &amp; Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.</p>  <p align="left">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        </p>  <p align="left"><strong>CONTACT:</strong></p>  <p align="left">Schall, Brown &amp; Schwartz LLP<br></br>Brian Schall, Esq.,<br></br>Andrew Brown, Esq.,<br></br>David Schwartz, Esq.,<br></br><a href="https://www.globenewswire.com/Tracker?data=0c8qlGmAZmm4DaYtx84VPl3KmO5X6Wi2WxLIFpBw0GWE-UTzAThpNUQf7ADOmGCZ-YU50d4oJmvEi6WrxXDdbELa2xv6RQcnpR_0iyCH-mA=" rel="nofollow" target="_blank">www.schallfirm.com</a><br></br>Office: 310-301-3335<br></br><a href="https://www.globenewswire.com/Tracker?data=8dULeFxMZ4vwo3UUbIEPfCcGkOXMi3XcbTKrkI3PQbgIbSt1a8EW9vmv1eO4jFpAKuYRg-qqYeyO_VCLneCw0om25b94HUkYC71XaM6MF9A=" rel="nofollow" target="_blank"><u>info@schallfirm.com</u></a></p>  <p align="left"><strong>SOURCE:</strong></p>  <p align="left"><strong> </strong>Schall, Brown &amp; Schwartz LLP</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTgwMzI5OSM3NzU3ODQ4IzIxMjM4NjI="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/MGM1MGQxYjctYWUzMi00NzRmLWIwMjYtYzE4MzU1NDg3ZmMwLTExMzU0MzMtMjAyNi0wOC0wNC1lbg==/tiny/Schall-Law.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/0b1ae5f6-3843-4b48-9c73-0b3760ba856a"><img src="https://ml.globenewswire.com/media/0b1ae5f6-3843-4b48-9c73-0b3760ba856a/small/logo-sbs-jpg.jpg" border="0" width="150" height="145" alt="Primary Logo"></img></a></p>

Schall, Brown & Schwartz filed a securities class action against Insulet (PODD) alleging misleading statements tied to manufacturing controls and a March 2026 Pod product recall. The case covers February 21, 2025 to May 26, 2026 with a deadline of August 31, 2026. The suit introduces downside risk to PODD’s valuation until facts are resolved.

News insight

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law

AI summary

Sentiment rationale

Key facts

Legal